Pei Dong, Wensu Wei, Yulu Peng, Deling Wang, Lijuan Jiang, Zhiling Zhang, Tingxuan Huang, Xi Zhong, Shengjie Guo, Hui Han, Wei Xiong, Xiuyu Cai, Fangjian Zhou. "Anlotinib combined with sintilimab as first-line treatment in patients with advanced non-clear cell renal cell carcinoma (nccRR): Preliminary results from an exploratory prospective multicentre clinical study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4526